MMP9 and triple-A syndrome: While our initial in vitro experiments showed that DFO attenuated AngII-induced endothelial dysfunction and activation, we unexpectedly found that DFO augmented the severity of AngII-induced AAA, partially due to an aberrant increased HIF-1α, MMP-2 and MMP-9 expression.